APIXABAN FOR THE REDUCTION OF THROMBO-EMBOLISM IN PATIENTS WITH DEVICE-DETECTED SUB-CLINICAL ATRIAL FIBRILLATION

Twitter


Atrial high-rate episodes (AHRE): prevalence, stroke risk, implications for management, and clinical gaps in evidence "AHRE slightly incr stroke risk (0.8-1%/year) compared w/patients w/o AHRE.” Co-auth incl Artesia Investigator Béla Merkely @semmelweishu https://t.co/i18WOvaGqW

Congratulations to #ARTESiA Spain for reaching their 300th enrollment milestone!! A special thank you to all the Principal Investigators and Dr. Juan Benezet @JuanBenezet, Spain National Leader, for your continued leadership! @PHRIresearch https://t.co/QrFW0xfaJI

We look forward to see our #ARTESiA Belgian site-representatives in Brussels for the #BHRM Investigator Meeting on Thursday! Safe travels! @PHRIresearch @GHMairesse https://t.co/Oy1OjcFvUR

LinkedIn